MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
42.39
+1.30 (3.16%)
At close: Jan 22, 2026, 4:00 PM EST
42.39
0.00 (0.00%)
After-hours: Jan 22, 2026, 5:17 PM EST
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.9 billion as of January 22, 2026. Its market cap has increased by 206.39% in one year.
Market Cap
1.90B
Enterprise Value
1.57B
1-Year Change
206.39%
Ranking
Category
Stock Price
$42.39
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.90B, an increase of 273.47%. That is a compound annual growth rate of 164.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.85B | 30.28% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 2.02B |
| Aurinia Pharmaceuticals | 1.98B |
| Monte Rosa Therapeutics | 1.97B |
| Vericel | 1.97B |
| Ardelyx | 1.96B |
| Corvus Pharmaceuticals | 1.89B |
| MannKind | 1.84B |
| Sionna Therapeutics | 1.83B |